Xuan Li

5PUBLICATIONS
8CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 04, 2022
DGKZ promotes TGFβ signaling pathway and metastasis in triple-negative breast cancer by suppressing lipid raft-dependent endocytosis of TGFβR2.

Yuanyuan Zhao, Hefen Sun, Xuan Li

|Dec 26, 2021
Conjoint analysis of circulating tumor cells and solid tumors for exploring potential prognostic markers and constructing a robust novel predictive signature for breast cancer.

Xuan Li, Hefen Sun, Qiqi Liu

|Jun 02, 2021
A pharmacophore-based classification better predicts the outcomes of HER2-negative breast cancer patients receiving the anthracycline- and/or taxane-based neoadjuvant chemotherapy.

Xuan Li, Hefen Sun, Qiqi Liu

|Jun 02, 2018
Clinicopathological and Prognostic Significance of Cancer Antigen 15-3 and Carcinoembryonic Antigen in Breast Cancer: A Meta-Analysis including 12,993 Patients.

Xuan Li, Danian Dai, Bo Chen

|Feb 07, 2018
Efficacy of PI3K/AKT/mTOR pathway inhibitors for the treatment of advanced solid cancers: A literature-based meta-analysis of 46 randomised control trials.

Xuan Li, Danian Dai, Bo Chen

Pageof 1

Frequent Collaborators

1 joint publications

Xiaoming Xie

1 joint publications

Weidong Wei

1 joint publications

Yuanyuan Zhao

1 joint publications

Hefen Sun